Diabetology — Find Specialists & Top Hospitals Worldwide | MyMedicPlus

Diabetology is a subspecialty of endocrinology dedicated exclusively to the diagnosis, management, and prevention of diabetes mellitus in all its forms and the complex metabolic disorders that accompany it. While endocrinologists manage the full breadth of hormonal disorders, diabetologists focus their practice on the growing global epidemic of diabetes, which affects over 500 million people worldwide and remains a leading cause of blindness, kidney failure, lower limb amputation, cardiovascular disease, and premature death.

Diabetology is an inherently multidisciplinary field. The optimal care of a person with diabetes requires coordination with dietitians for medical nutrition therapy, diabetes nurse educators for self-management training, podiatrists for foot care, ophthalmologists for retinal screening, nephrologists for kidney disease management, and cardiologists for cardiovascular risk reduction. The diabetologist serves as the central coordinator of this integrated care team.

The field has been transformed in recent years by technological advances including continuous glucose monitoring (CGM) systems that provide real-time glucose readings every few minutes, and closed-loop insulin delivery systems (hybrid closed-loop or artificial pancreas) that automatically adjust insulin doses based on CGM data. These innovations have dramatically improved the safety and effectiveness of insulin therapy, particularly for patients with type 1 diabetes. Concurrently, a new generation of pharmacological agents — GLP-1 receptor agonists (semaglutide, liraglutide) and SGLT-2 inhibitors (empagliflozin, dapagliflozin) — have demonstrated cardiovascular and renal protective benefits beyond glucose lowering, fundamentally changing type 2 diabetes management guidelines.

Diabetologists manage the full spectrum of diabetes and related metabolic conditions:

• Type 1 diabetes mellitus (T1DM): Autoimmune destruction of pancreatic beta cells leading to absolute insulin deficiency; requires lifelong insulin therapy, often managed with multiple daily injections or insulin pump therapy with CGM.
• Type 2 diabetes mellitus (T2DM): The most common form of diabetes, characterised by insulin resistance and progressive beta cell dysfunction; treated with lifestyle modification, oral agents, injectable medications, and insulin as the disease progresses.
• Gestational diabetes mellitus (GDM): Glucose intolerance first diagnosed during pregnancy, requiring close monitoring and management to prevent maternal and neonatal complications; women with GDM have a significantly elevated lifetime risk of developing type 2 diabetes.
• Maturity-onset diabetes of the young (MODY): Rare monogenic forms of diabetes caused by single gene mutations (e.g., GCK-MODY, HNF1A-MODY); important to recognise as they require specific treatment regimens different from type 1 or type 2 diabetes.
• Secondary diabetes: Diabetes arising from other medical conditions including pancreatitis, haemochromatosis, Cushing syndrome, acromegaly, or medication use (corticosteroids, antipsychotics).
• Latent autoimmune diabetes in adults (LADA): A slowly progressive autoimmune form of diabetes that is often initially misdiagnosed as type 2 diabetes in adults; identified by positive GAD antibodies.
• Diabetic ketoacidosis (DKA): Acute, life-threatening metabolic emergency characterised by hyperglycaemia, ketonaemia, and metabolic acidosis; most common in type 1 diabetes but can occur in type 2.
• Hyperosmolar hyperglycaemic state (HHS): Severe hyperglycaemia without significant ketosis in type 2 diabetes, causing extreme dehydration and altered consciousness; requires emergency hospitalisation.
• Prevention and management of diabetes complications: Diabetic nephropathy, diabetic retinopathy, diabetic peripheral neuropathy, autonomic neuropathy, and diabetic foot disease.
• Recurrent hypoglycaemia: Frequent low blood glucose episodes, particularly in insulin-treated patients, leading to impaired hypoglycaemia awareness — a dangerous state requiring specialist reassessment of insulin regimens.

Diabetologists use a combination of diagnostic tests, monitoring technologies, and therapeutic interventions:

• Continuous glucose monitoring (CGM) initiation and management: Real-time interstitial glucose monitoring via subcutaneous sensor (e.g., Dexterity G7, FreeStyle Libre 3); diabetologists interpret CGM ambulatory glucose profile (AGP) reports, adjust insulin regimens, and educate patients on trend interpretation.
• Insulin pump therapy (CSII) initiation: Continuous subcutaneous insulin infusion via external pump; diabetologists select appropriate candidates, programme basal rates and bolus ratios, troubleshoot pump malfunctions, and train patients in pump management.
• Hybrid closed-loop (artificial pancreas) system setup: Advanced automated insulin delivery systems (e.g., Tandem Control-IQ, Medtronic MiniMed 780G) that adjust basal insulin automatically using CGM data; require specialist training and ongoing optimisation.
• HbA1c and comprehensive metabolic assessment: Regular measurement of glycated haemoglobin reflecting 2–3 month glucose average, combined with lipid panel, kidney function (eGFR, urine albumin-to-creatinine ratio), liver function, and thyroid function.
• Structured diabetes education programmes: Certified programmes such as DAFNE (Dose Adjustment For Normal Eating) for type 1, or DESMOND/XPERT for type 2, delivered by specialist nurses and dietitians in collaboration with the diabetologist.
• Peripheral neuropathy assessment: Monofilament testing, vibration perception threshold measurement, and nerve conduction studies to identify early diabetic peripheral neuropathy before painful or dangerous complications develop.
• Retinal photography and ophthalmology coordination: Annual fundus photography or dilated fundus examination to screen for diabetic retinopathy; diabetologists coordinate referral to ophthalmologists for significant retinopathy requiring laser or anti-VEGF treatment.
• Insulin initiation and titration counselling: Guidance on initiating basal insulin in type 2 diabetes patients, selection of appropriate insulin formulations, dose titration protocols, and management of hypoglycaemia.

Primary care physicians and general practitioners manage the majority of patients with well-controlled type 2 diabetes effectively. However, referral to a diabetologist is appropriate in several specific situations where specialist expertise is required.

Refer when glucose control is inadequate despite appropriate escalation of therapy — specifically, when HbA1c remains above 8.0% (64 mmol/mol) despite two or more glucose-lowering medications at optimal doses, or when persistent hypoglycaemia makes safe intensification impossible without specialist guidance on insulin regimen design.

Refer for insulin initiation or complex insulin management — particularly for basal-bolus multiple daily injection regimens, insulin pump therapy, or hybrid closed-loop systems, which require specialised training and ongoing optimisation. Patients with newly diagnosed type 1 diabetes always require urgent diabetologist referral for immediate insulin initiation, education, and technology setup.

Refer women with diabetes who are pregnant or planning pregnancy — pre-conception HbA1c optimisation, folic acid dosing, medication review, and intensive monitoring throughout pregnancy require specialist co-management. Gestational diabetes not controlled with dietary measures requires diabetologist-supervised insulin management.

Refer when diabetes complications are developing — new or worsening microalbuminuria, estimated GFR falling below 60 mL/min/1.73m², painful neuropathy, severe autonomic neuropathy, or recurrent hypoglycaemia unawareness all benefit from specialist review. Refer immediately for suspected MODY (young, thin patient with unexpected diabetes diagnosis, family history) or secondary diabetes requiring investigation of the underlying cause.

Diabetologists in the USA are endocrinologists who have developed a subspecialty focus on diabetes during or after their fellowship training. The training pathway begins with a 4-year medical degree (MD or DO), followed by a 3-year internal medicine residency during which broad clinical skills are acquired across all organ systems. After passing the ABIM internal medicine board examination, candidates apply for an endocrinology and metabolism fellowship.

The endocrinology, diabetes, and metabolism fellowship lasts 2 years at a minimum (3 years at research-intensive programmes). During fellowship, trainees rotate through clinical diabetes services, thyroid disease, reproductive endocrinology, adrenal and pituitary disorders, and bone metabolism. Dedicated diabetes technology clinics — CGM initiation, insulin pump management, and closed-loop system oversight — are increasingly central to fellowship training. The ABIM board examination in endocrinology, diabetes, and metabolism certifies competency across the full scope of the specialty.

In countries such as India, the UK, and Germany, dedicated diabetology training pathways or fellowship programmes exist separate from general endocrinology, reflecting the scale and importance of diabetes management in those healthcare systems. In the UK, clinical diabetes is a subspecialty within the Endocrinology and Diabetes CCT programme, and the Association of British Clinical Diabetologists (ABCD) represents the specialty professionally. Diabetes nurse educators, registered dietitians with diabetes specialisation, and certified diabetes care and education specialists (CDCES, formerly CDE) are essential members of the multidisciplinary diabetes team.

Your primary care physician is the appropriate first point of contact for newly diagnosed or well-controlled diabetes. When specialist care is needed, ask for a referral to an endocrinologist or diabetologist — verifying board certification through the ABIM online directory. Look for providers affiliated with academic medical centres or dedicated diabetes centres, which offer multidisciplinary teams including diabetes nurse educators, dietitians, and access to the latest technology.

For patients with type 1 diabetes or those requiring insulin pump or CGM management, seek a specialist who specifically manages large numbers of technology-using patients and participates in updating their knowledge of continuous glucose monitoring and closed-loop systems, which evolve rapidly.

For your first appointment, bring your glucose logbook or CGM device download, recent HbA1c and laboratory results, a complete medication list, and information on any diabetes complications or related conditions. Expect a comprehensive review of your glucose patterns, medication regimen, nutrition habits, and complications screening. Diabetes management requires ongoing engagement — most patients see their diabetologist every 3–6 months, with more frequent visits during active regimen changes or pregnancy.